Page last updated: 2024-12-10

senecionine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

senecionine: RN given refers to parent cpd; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

senecionine : A pyrrolizidine alkaloid isolated from the plant species of the genus Senecio. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID5280906
CHEMBL ID362153
CHEBI ID9107
SCHEMBL ID896098
MeSH IDM0053770

Synonyms (47)

Synonym
wln: t55-12-1a q en iovy ovo butj ku2 m nq n
senecionan-11, 12-hydroxy-
wln: t55-12- 1a q en iovy ovo butj ku2 m1 nq n1
nsc-89935
senecionin
CHEBI:9107 ,
senecionan-11,16-dione, 12-hydroxy-
hsdb 3535
nsc 89935
ai3-51771
brn 0934445
ccris 4340
(z)-ethylidene-hydroxy-dimethyl-[?]dione
12-hydroxysenecionan-11,16-dione
nsc89935
aureine
130-01-8
C06176
senecionine
NCGC00163621-01
senecionine, >=95.0% (gc)
CHEMBL362153
unii-bo6n1u5yg6
(1,6)dioxacyclododecino(2,3,4-gh)pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-, (3z,5r,6r,14ar,14br)-
bo6n1u5yg6 ,
(-)-senecionine
senecionine [mi]
SCHEMBL896098
CCG-208634
AC-34604
[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione,3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-,(3z,5r,6r,14ar,14br)-
mfcd00221720
J-005736
senecionine, analytical standard
bdbm50480301
AKOS037514834
(5r,6r,9a1r,14ar,z)-3-ethylidene-6-hydroxy-5,6-dimethyl-3,4,5,6,9,9a1,11,13,14,14a-decahydro-[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione
Q2083871
DTXSID40871615 ,
CS-0022892
HY-N2560
[1,6]dioxacyclododecino[2,3,4-gh]pyrrolizine-2,7-dione, 3-ethylidene-3,4,5,6,9,11,13,14,14a,14b-decahydro-6-hydroxy-5,6-dimethyl-, (3z,5r,6r,14ar,14br)-
(1r,4z,6r,7r,17r)-4-ethylidene-7-hydroxy-6,7-dimethyl-2,9-dioxa-14-azatricyclo[9.5.1.014,17]heptadec-11-ene-3,8-dione
AS-79841
A905119
dtxcid501474669
senecionine 100 microg/ml in methanol:water

Research Excerpts

Overview

Senecionine (SEN) is a representative of the hepatotoxic pyrrolizidine alkaloids.

ExcerptReferenceRelevance
"Senecionine (SEN) is a representative of the hepatotoxic pyrrolizidine alkaloids. "( Identification of the UDP-glucuronosyltransferase isozyme involved in senecionine glucuronidation in human liver microsomes.
He, YQ; Liu, HX; Liu, Y; Lu, YL; Wang, CH; Wang, ZT; Xiong, AZ; Xu, LL; Yang, L; Zhang, BF, 2010
)
2.04

Toxicity

Senecionine (SCO), senkirkin (SKK) and seneciphyllin (SCP) and their toxic effects in cattle were studied. TE and TA induced similar acute liver injuries, but senECionine was considerably more toxic than these extracts.

ExcerptReferenceRelevance
" LC was slightly more toxic to control hepatocytes than SC in the graded response range of 10-160 microM."( Influences of various xenobiotic inducers on cytocidal toxicity of lasiocarpine and senecionine in primary cultures of rat hepatocytes.
Cameron, RC; Farber, E; Hayes, MA; Jago, MV; Roberts, E; Safe, SH, 1984
)
0.49
" The rat LD50 of most alkaloids known to be significant for human health are in the range of 34-300 mg/kg."( Differing embryotoxic effects of senecionine and senecionine-N-oxide on the chick embryo.
Halasková, M; Peterka, M; Roeder, E; Sarin, S; Wiedenfeld, H, 1994
)
0.57
" In this study the content of the alkaloids senecionine (SCO), senkirkin (SKK) and seneciphyllin (SCP) and their toxic effects in cattle were studied."( Interplant alkaloid variation and Senecio vernalis toxicity in cattle.
Brimer, L; Friis, C; Skaanild, MT, 2001
)
0.57
"Pyrrolizidine alkaloids (PAs) are feeding deterrents and toxic compounds to generalist herbivores."( Toxicity of pyrrolizidine alkaloids to Spodoptera exigua using insect cell lines and injection bioassays.
Klinkhamer, PG; Leiss, KA; Nuringtyas, TR; van Oers, MM; Verpoorte, R, 2014
)
0.4
" TE and TA induced similar acute liver injuries, but senecionine was considerably more toxic than these extracts."( Comparative analysis of toxic components in different medicinal parts of Gynura japonica and its toxicity assessment on mice.
Ding, W; Fang, L; Shao, Y; Wang, Z; Xiong, A; Yang, L; Yang, X; Zhang, S; Zheng, J, 2019
)
0.76
" As a continuation of our investigation into the toxicity and safety assessment of pyrrolizidine alkaloid (PA)-containing herbs, we generated a UGT1A4-humanized (hUGT1A4) transgenic mouse model to systematically study the toxicity, metabolism network, and toxicokinetic characteristics of senecionine (a representative toxic PA) and compared with that in the wide-type controls in parallel."( Firm evidence for the detoxification of senecionine-induced hepatotoxicity via N-glucuronidation in UGT1A4-humanized transgenic mice.
Chen, Y; Jia, XL; Wang, CH; Wang, WQ; Wang, ZT; Xiong, AZ; Yang, L, 2022
)
1.17

Pharmacokinetics

ExcerptReferenceRelevance
" The developed method was successfully applied to the in vivo pharmacokinetic study in rats after intravenous administration of SEN and ADO."( Simultaneous determination of senecionine, adonifoline and their metabolites in rat serum by UPLC-ESIMS and its application in pharmacokinetic studies.
Gao, J; He, Y; Li, Y; Wang, C; Wang, Z; Xiong, A; Yang, L, 2009
)
0.64
" This study determined the differences in the in vivo pharmacokinetic behavior of senecionine (SEN), adonifoline (ADO), and their main metabolites in rats after intravenous administration and oral administration by ultraperformance liquid chromatography/electrospray ionization mass spectrometry."( The comparative pharmacokinetics of two pyrrolizidine alkaloids, senecionine and adonifoline, and their main metabolites in rats after intravenous and oral administration by UPLC/ESIMS.
Cheng, X; Gao, J; He, Y; Li, Y; Ma, Y; Wang, C; Wang, Z; Xiong, A; Yang, L, 2011
)
0.83

Bioavailability

ExcerptReferenceRelevance
" Upon intravenous administration and oral administration of SEN and ADO, significant differences in pharmacokinetics were observed, with the SEN and ADO being absorbed fast with lower bioavailability and being quickly metabolized to PA N-oxides and hydroxylation products of PAs or their N-oxides."( The comparative pharmacokinetics of two pyrrolizidine alkaloids, senecionine and adonifoline, and their main metabolites in rats after intravenous and oral administration by UPLC/ESIMS.
Cheng, X; Gao, J; He, Y; Li, Y; Ma, Y; Wang, C; Wang, Z; Xiong, A; Yang, L, 2011
)
0.61

Dosage Studied

ExcerptRelevanceReference
" Lactating rats dosed with these differently labelled pyrrolizidine alkaloids (PAs) excreted within 3 h approx."( Transfer of [3H]pyrrolizidine alkaloids from Senecio vulgaris L. and metabolites into rat milk and tissues.
Heim, T; Lüthy, J; Schlatter, C, 1983
)
0.27
" Male Sprague-Dawley rats (n = 4), aged 8-9 weeks, were dosed per os."( The toxicity of Senecio inaequidens DC.
Bekker, L; Botha, CJ; Dimande, AF; Labuschagne, L; Prozesky, L; Retief, E; Rösemann, GM, 2007
)
0.34
"001) for both dosing routes in rats."( The comparative pharmacokinetics of two pyrrolizidine alkaloids, senecionine and adonifoline, and their main metabolites in rats after intravenous and oral administration by UPLC/ESIMS.
Cheng, X; Gao, J; He, Y; Li, Y; Ma, Y; Wang, C; Wang, Z; Xiong, A; Yang, L, 2011
)
0.61
" PA N-oxide-induced hepatotoxicity was further confirmed on mice orally dosed of herbal extract containing 170 μmol PA N-oxides/kg/day, with its hepatotoxicity similar to but potency much lower than the corresponding PAs."( First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.
Fu, PP; Gao, H; Li, N; Lin, G; Ma, J; Ruan, J; Wang, J; Xue, J; Yang, M; Ye, Y, 2017
)
0.46
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
lactoneAny cyclic carboxylic ester containing a 1-oxacycloalkan-2-one structure, or an analogue having unsaturation or heteroatoms replacing one or more carbon atoms of the ring.
pyrrolizidine alkaloidAn alkaloid based on the structure of pyrrolizidine.
tertiary alcoholA tertiary alcohol is a compound in which a hydroxy group, -OH, is attached to a saturated carbon atom which has three other carbon atoms attached to it.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (6)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency35.48130.003245.467312,589.2998AID2517
Chain A, ATP-DEPENDENT DNA HELICASE Q1Homo sapiens (human)Potency28.18380.125919.1169125.8920AID2549
thioredoxin reductaseRattus norvegicus (Norway rat)Potency25.11890.100020.879379.4328AID588453
flap endonuclease 1Homo sapiens (human)Potency100.00000.133725.412989.1251AID588795
DNA polymerase iota isoform a (long)Homo sapiens (human)Potency100.00000.050127.073689.1251AID588590
DNA polymerase kappa isoform 1Homo sapiens (human)Potency89.12510.031622.3146100.0000AID588579
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (8)

Assay IDTitleYearJournalArticle
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID397122Inhibition of HIV1 RT
AID697853Inhibition of horse BChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
AID339034Cytotoxicity against human A204 cells after 24 hrs by soft agar colony forming assay
AID243422log (1/Km) value for human liver microsome cytochrome P450 3A42005Bioorganic & medicinal chemistry letters, Sep-15, Volume: 15, Issue:18
Modeling K(m) values using electrotopological state: substrates for cytochrome P450 3A4-mediated metabolism.
AID697852Inhibition of electric eel AChE at 2 mg/ml by Ellman's method2012Bioorganic & medicinal chemistry, Nov-15, Volume: 20, Issue:22
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (84)

TimeframeStudies, This Drug (%)All Drugs %
pre-199022 (26.19)18.7374
1990's20 (23.81)18.2507
2000's12 (14.29)29.6817
2010's23 (27.38)24.3611
2020's7 (8.33)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 36.87

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index36.87 (24.57)
Research Supply Index4.51 (2.92)
Research Growth Index4.64 (4.65)
Search Engine Demand Index53.49 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (36.87)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (1.11%)4.05%
Observational0 (0.00%)0.25%
Other89 (98.89%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]